Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?

医学 癌症 精密医学 内科学 肿瘤科 病理
作者
Timothée Olivier,Eugenio Fernández,Sana Intidhar Labidi‐Galy,Pierre‐Yves Dietrich,Verónica Rodríguez-Bravo,Giulia Baciarello,Karim Fizazi,Anna Patrikidou
出处
期刊:Cancer Treatment Reviews [Elsevier BV]
卷期号:97: 102204-102204 被引量:51
标识
DOI:10.1016/j.ctrv.2021.102204
摘要

The concept of Cancer of Unknown Primary (CUP) has evolved with the advent of medical oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore not exceptionally rare. Within CUPs can be identified a subset of favourable prognosis tumours, however the vast majority of CUP patients belongs to a poor prognosis group.CUP features significant oncological challenges, such as unravelling biological and transversal issues, and most importantly, improving patient’s outcomes. In that regard, CUP patients’ outcomes regrettably showed minimal improvement for decades and CUP remains a cancer group of very poor prognosis.The biology of CUP has two main hypotheses. One is that CUP is a subgroup of a given primary cancer, where the primary is present but cannot be seen due to its small size. The other, the “true” CUP hypothesis, states that CUP share features that make them a specific entity, whatever their tissue of origin. A true biological signature has not yet been described, but chromosomal instability is a hallmark of poor prognosis CUP group.Precision oncology, despite achieving identifying the putative origin of the CUP, so far failed to globally improve outcomes of patients. Targeting molecular pathways based on molecular analysis in CUP management is under investigation. Immunotherapy has not shown ground-breaking results, to date. Accrual is also a crucial issue in CUP trials.Herein we review CUP history, biological features and remaining questions in CUP biology, the two main approaches of molecular oncology in CUP management, in order to draw perspectives in the enormous challenge of improving CUP patient outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lan完成签到,获得积分10
1秒前
NexusExplorer的应助被内向代珊采纳,获得10
1秒前
包包酱完成签到,获得积分10
2秒前
Han发布了新的文献求助10
3秒前
霁月发布了新的文献求助10
5秒前
霁月发布了新的文献求助10
5秒前
冷艳的寒天的应助被wzhang采纳,获得10
5秒前
霁月发布了新的文献求助10
5秒前
霁月发布了新的文献求助10
5秒前
Maestro_S的应助被结实绾绾采纳,获得100
5秒前
领导范儿的应助被香香香采纳,获得10
6秒前
6秒前
8秒前
正版DY完成签到,获得积分10
8秒前
8秒前
hfkfk完成签到,获得积分10
8秒前
q2026完成签到 ,获得积分10
9秒前
fantasy的应助被盖福鹤采纳,获得10
11秒前
11秒前
龙达绝澈发布了新的文献求助10
11秒前
sxk完成签到,获得积分10
11秒前
12秒前
水煮电吹风的应助被egg1000采纳,获得10
13秒前
zcf完成签到,获得积分10
13秒前
cvmax完成签到,获得积分10
14秒前
阿强完成签到,获得积分10
14秒前
ally发布了新的文献求助10
14秒前
15秒前
water完成签到,获得积分10
15秒前
陈凌雪完成签到,获得积分10
15秒前
16秒前
16秒前
ccf完成签到,获得积分20
17秒前
17秒前
FeCl发布了新的文献求助20
17秒前
18秒前
18秒前
18秒前
顾矜的应助被light采纳,获得10
19秒前
lc完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187612
求助须知:如何正确求助?哪些是违规求助? 9575734
关于积分的说明 21842594
捐赠科研通 7785476
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559478
邀请新用户注册赠送积分活动 2481952